IAP Immunization Schedule

‘IAP Immunization Timetable 2012’
I. IAP recommended vaccines for routine use


Age
(completed  weeks/months/years)

Vaccines

Comments

Birth

BCG
OPV 0
Hep-B 1

Administer Hep-B vaccine to all newborns before hospital discharge

6 weeks

DTwP 1/DTaP 1
IPV 1
Hep-B 2
Hib 1
Rotavirus* 1
PCV 1

IPV: two doses instead of 3 can be used for primary series if started at 8 and 16 weeks

Rotavirus vaccine: Only 2 doses of RV-1 and 3 doses of RV-5  

10 weeks

DTwP 2/DTaP 2
IPV 2
Hib 2
Rotavirus 2
PCV 2

 

Polio: Additional doses of OPV on all NIDs/SNIDs

14 weeks

DTwP 3/DTaP 3
IPV 3
Hib 3
Rotavirus* 3
PCV 3

 

Polio: Additional doses of OPV on all NIDs/SNIDs
Only 2 doses of RV1 are needed.

6 months

OPV 1
Hep-B 3

The final (third or fourth) dose in the HepB vaccine series should be administered no earlier than age 24 weeks and at least 16 weeks after the first dose.

9 months

OPV 2
Measles

 

12 months

Hep-A 1

 

15 months

MMR 1
Varicella 1
PCV booster

The risk of breakthrough varicella is lower if given 15 months onwards.

16 to 18 months

DTwP B1/DTaP B1
IPV B1
Hib B1

 

The first booster (4thth dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose.

18 months

Hep-A 2

2 doses of both killed and live hepatitis-A vaccines

2 years

Typhoid 1

Typhoid revaccination every 3 years, if Vi-polysaccharide vaccine is used.

5 years

DTwP B2/DTaP B2
OPV 3
MMR 2
Varicella 2
Typhoid 2

MMR: the 2nd dose can be given at anytime 4-8 weeks after the 1st dose.

Varicella: the 2nd dose can be given at anytime 3 months after the 1st dose.

10 to 12 years

Tdap/Td
HPV

Tdap: is preferred to Td followed by Td every 10 years.

HPV: Only for females, 3 doses at 0, 1-2 (depending on brands) and 6 months.

 

II. IAP recommended vaccines for High-risk* children (Vaccines under special circumstances): 
1-Influenza Vaccine
2-Meningococcal Vaccine
3-Japanese Encephalitis Vaccine
4-Cholera Vaccine
5-Rabies Vaccine
6-Yellow Fever Vaccine
7-Pneumococcal Polysaccharide vaccine (PPSV 23)

 

* High-risk category of children:

  • Congenital or acquired immunodeficiency (including HIV infection), 
  • Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including nephrotic syndrome), liver disease and diabetes mellitus
  • Children on long term steroids, salicylates, immunosuppressive or radiation therapy
  • Diabetes mellitus, Cerebrospinal fluid leak,  Cochlear implant, Malignancies,
  • Children with functional/ anatomic asplenia/ hyposplenia
  • During disease outbreaks
  • Laboratory personnel and healthcare workers
  • Travelers